NGVT FINANCIAL STATEMENTS

Ingevity Corp — balance sheet, income statement and cash flow trends

NGVTIngevity Corp

🇺🇸 USA · NYSE · Basic Materials · Specialty Chemicals

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue1.2 B $-10.3%

Gross Profit476 M $+1.6%

Operating Income276.5 M $-0.1%

EBITDA17.1 M $—

Net Income-127.8 M $—

Peer Comparison· Specialty Chemicals

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
NGVT	-10.3%	39.3%	1.4%	-10.6%
SASA	4.0%	7.7%	15.6%	-36.0%
DNL	-16.6%	27.9%	17.8%	4.5%
IMCD	1.2%	17.7%	10.9%	4.5%
ORI	1.8%	19.2%	17.3%	3.1%
BNR	-9.5%	18.6%	7.9%	1.5%
Industry median	1.2%	26.7%	14.7%	3.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
NGVT	-10.3%	39.3%	1.4%	-10.6%
KWR	6.3%	34.4%	8.8%	0.2%
CC	0.1%	15.1%	2.3%	-7.1%
HWKN	11.2%	22.6%	16.2%	7.5%
MTX	2.5%	24.9%	17.3%	7.6%
ASH	-7.2%	25.2%	-16.3%	-39.0%
Industry median	1.2%	26.7%	14.7%	3.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity38.9 M $2%
Current Liabilities409.4 M $25%
Long-term Liabilities1.2 B $73%

Key Figures

YoY change

Total Assets1.7 B $-19.7%

Total Liabilities1.6 B $-11.5%

Total Equity38.9 M $-83.4%

Cash & ST Investments95.4 M $+33.4%

Total Debt1.2 B $-13.7%

Net Debt1.1 B $-16.1%

Peer Comparison· Specialty Chemicals

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
NGVT	1.42	3,199.7%	67.21	2.4%
SASA	0.63	83.7%	14.70	48.5%
DNL	1.27	39.7%	2.15	57.8%
IMCD	1.73	83.4%	2.81	44.0%
ORI	1.31	86.9%	1.77	38.5%
BNR	1.74	75.4%	2.31	40.0%
Industry median	1.87	63.0%	2.15	46.9%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
NGVT	1.42	3,199.7%	67.21	2.4%
KWR	2.45	65.2%	4.31	49.1%
CC	1.82	2,042.3%	29.00	3.0%
HWKN	2.21	49.0%	1.47	53.3%
MTX	2.13	55.9%	1.75	49.9%
ASH	3.06	79.2%	-3.86	41.5%
Industry median	1.87	63.0%	2.15	46.9%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow303.8 M $+82.9%

Capital Expenditures58 M $-18.3%

Free Cash Flow245.8 M $+158.5%

Dividends Paid——

Peer Comparison· Specialty Chemicals

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
NGVT	25.1%	20.3%	4.8%	-237.7%
SASA	13.5%	3.8%	10.3%	-37.5%
DNL	9.3%	-0.2%	9.5%	205.3%
IMCD	6.7%	6.5%	0.3%	148.1%
ORI	11.6%	6.2%	5.4%	372.9%
BNR	6.4%	4.4%	2.0%	415.2%
Industry median	9.6%	5.8%	5.0%	111.7%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
NGVT	25.1%	20.3%	4.8%	-237.7%
KWR	7.4%	7.4%	1.3%	3,364.4%
CC	5.7%	2.6%	3.1%	-80.8%
HWKN	13.3%	7.9%	5.4%	177.0%
MTX	10.8%	5.6%	5.3%	142.4%
ASH	22.4%	18.5%	3.9%	-57.4%
Industry median	9.6%	5.8%	5.0%	111.7%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NGVT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.